Tabalumab in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate and Naive to Biologic Therapy: A Phase II, Randomized, Placebo‐Controlled Trial - Concepedia

Concepedia

Publication | Closed Access

Tabalumab in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate and Naive to Biologic Therapy: A Phase II, Randomized, Placebo‐Controlled Trial

69

Citations

14

References

2013

Year

Mark C. Genovese, S. Bojin, Ilaria Biagini, Eugenia Mociran, D. Cristei, G. Mirea, Liviu Georgescu, J Sloan-Lancaster

Arthritis & Rheumatism

Abstract

Tabalumab treatment significantly reduces the signs and symptoms of rheumatoid arthritis and has a safety profile similar to that seen with placebo treatment.

References

	Year	Citations

Page 1